BioSpace News Archive

Experienced industry leader to head Complexa’s clinical development programs

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), today announced that its Annual Report on From 20-F for the fiscal year ended March 31, 2019

ViewRay, Inc. (Nasdaq: VRAY) announced today the acceptance of publication by the International Journal of Radiation Oncology, Biology and Physics of the first prospective clinical trial of MR-guided radiation therapy (MRgRT) in patients with localized prostate cancer.

MilliporeSigma, a leader in genome editing, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing MilliporeSigma’s patent application claims covering CRISPR gene-editing technology, bringing the number of patents to 20 worldwide.

Spherix Incorporated, (NASDAQ: SPEX) a technology development company committed to the fostering of innovative ideas, today issued a letter to shareholders:

Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Lawrence Klein, Ph.D., to its Board of Directors.

Agilent Technologies Inc. (NYSE: A) today announced it has received a Learning!100 Award from Elearning! Media Group (EMG)

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the company will participate in the following conference in September:

Genomind®, a leading mental health care company, and NeuroFlow, a health care analytics and technology company, today announced an agreement to partner their proprietary technology and clinical services to improve patient care across a broad spectrum of mental health conditions.

Harvest One Cannabis Inc. (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through its wholly-owned subsidiary Satipharm Ltd. (“Satipharm”) today announced it has expanded its product portfolio with the launch of CBD oil, now available online at www.satipharm.com.